Navigation Links
Daiichi Sankyo, Virtici and Celdara Medical Announce Collaboration to Identify and Progress High Potential Therapeutics
Date:1/8/2014

hi Sankyo's impressive capabilities, global reach, and open, collaborative culture make them ideal partners," said Jake Reder, Ph.D., President and Chief Executive Officer of Celdara Medical. "The team at Celdara Medical is excited to work hand-in-hand with Daiichi Sankyo on some of the most challenging problems in human health."

About Daiichi Sankyo


The Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets. While maintaining its portfolio of marketed pharmaceuticals for hypertension, hyperlipidemia, and bacterial infections, the Group is engaged in the development of treatments for thrombotic disorders and focused on the discovery of novel oncology and cardiovascular-metabolic therapies. Furthermore, the Daiichi Sankyo Group has created a "Hybrid Business Model," which will respond to market and customer diversity and optimize growth opportunities across the value chain. For more information about Daiichi Sankyo, please visit www.daiichisankyo.com.   

About Virtici, LLC

Founded in 2011, Virtici is a privately held product-development company headquartered in Seattle, Washington. Virtici's mission is to improve quality of life and save lives, and is primarily developing products to improve the way we diagnose and treat cancer, autoimmunity, and cardiovascular/metabolic diseases. Virtici, working closely with our affiliate Celdara Medical, partners with inventors and their research institutions, bringing the business and finance expertise to accelerate product development. Working with its partners in the pharmaceutical industry, Virtici connects the entire product development lifecycle by improving innovation, enhancing discovery and increasing product development efficiencies. Fo
'/>"/>

SOURCE Daiichi Sankyo, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Daiichi Sankyo Submits Edoxaban Marketing Authorization Application to the EMA for Once-Daily Use for Stroke Prevention in Atrial Fibrillation and for the Treatment and Prevention of Recurrence of Venous Thromboembolism
2. Daiichi Sankyos Once-Daily Edoxaban Meets Primary Efficacy Endpoint for Stroke Prevention and Superiority for the Principal Safety Endpoint Compared to Warfarin for Patients with Atrial Fibrillation in a Phase 3 Clinical Trial
3. Daiichi Sankyos Once-Daily Edoxaban Shows Comparable Efficacy and Superiority for the Principal Safety Endpoint Compared to Warfarin in a Phase 3 Study for the Treatment of Symptomatic VTE and Prevention of its Recurrence
4. Daiichi Sankyo CEO John Gargiulo Elected as National Pharmaceutical Councils Chairman of the Board
5. Daiichi Sankyo ha completato larruolamento dei pazienti per lo studio Hokusai-VTE su Edoxaban, il più ampio trial clinico di fase 3 per il trattamento delle tromboembolie venose ricorrenti
6. Daiichi Sankyo Completes Enrolment in Hokusai - VTE, investigating once-daily Edoxaban in the Largest Single Phase 3 Study for the Treatment and Prevention of Recurrence of VTE
7. Daiichi Sankyo, Inc. Receives FDA Approval to Package Product at New Facility in Bethlehem, PA
8. Kalila Medical Announces CE Mark Approval For The Vado Steerable Sheath Used During Atrial Fibrillation Procedures
9. Puritan Medical Products erhält zwei neue Patente für beflockte Tupfer in Japan
10. Agile Therapeutics Appoints Dr. Elizabeth Ijeoma Onyemelukwe Garner as Chief Medical Officer
11. Ensil Canada is Launching a New Medical Device: Publicly Traded Companies Are Invited to Acquire This Technology or Partner with Ensil Canada on the Marketing and Distribution of This New Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014  A Boston Scientific Corporation (NYSE: ... removability and preliminary long term stricture resolution of ... August issue of the peer-reviewed journal, Gastroenterology. ... being conducted in 11 countries and five continents, ... stents (FCSEMS) after extended indwell (i.e., up to ...
(Date:8/29/2014)... Medina Medical announced today that Mr. Engelson ... Board of Directors on August 18, 2014. Mr. Engelson ... experience, including over a decade of direct experience in ... Partner of the medical device incubator The Foundry, after ... start-ups. Mr. Engelson previously served as the Chief Financial ...
(Date:8/29/2014)... Aug. 29, 2014  BC Technical, the nation,s leading ... Medical Imaging, a leader in sales, service and installation ... allows BC Technical to continue to expand their resources ... and CT modalities. "We are committed ... Mark Alvarez , president and CEO of BC Technical. ...
Breaking Medicine Technology:Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2BC Technical Acquires Polaris Medical Imaging 2
... PDL BioPharma, Inc. (PDL, the Company) (NASDAQ: PDLI ... aggregate principal amount of its 3.75% Convertible Senior Notes due ... conversion rate will initially be 126.2985 shares of common stock ... conversion price of approximately $7.92 per share of common stock. ...
... May 10, 2011 Cardica, Inc. (Nasdaq: CRDC ... and nine months ended March 31, 2011. Cardica,s management will ... to discuss the financial results and provide an update on ... diligently to bring our first anticipated commercial microcutter device, the ...
Cached Medicine Technology:PDL BioPharma, Inc. Prices Offering of $135.0 Million of Convertible Senior Notes Due 2015 2PDL BioPharma, Inc. Prices Offering of $135.0 Million of Convertible Senior Notes Due 2015 3PDL BioPharma, Inc. Prices Offering of $135.0 Million of Convertible Senior Notes Due 2015 4Cardica Announces Fiscal 2011 Third Quarter Financial Results 2Cardica Announces Fiscal 2011 Third Quarter Financial Results 3Cardica Announces Fiscal 2011 Third Quarter Financial Results 4Cardica Announces Fiscal 2011 Third Quarter Financial Results 5Cardica Announces Fiscal 2011 Third Quarter Financial Results 6
(Date:9/1/2014)... City, NY (PRWEB) September 02, 2014 ... Brinkley, Office Manager at Gibson Orthopedics ... Woman of the Year. Ms. Brinkley is recognized ... administration. As the largest, most-recognized networking organization of ... and profession, the National Association of Professional Women ...
(Date:9/1/2014)... a well is drilled, fitted with a hand pump, ... for the first time? Half of them break down ... sufficient resources and training, these wells would be rendered ... North Carolina-Chapel Hill,s (UNC) Water Institute and Water and ... if local water communities collect fees for repairs and ...
(Date:9/1/2014)... UWDress.com, a well-known wedding dress manufacturer and retailer, ... bridesmaid dresses for its new and old clients. ... online category. What’s more, they are offered at very ... is specially launched to celebrate the coming of autumn. ... won great appreciation from worldwide clients. Now, the company ...
(Date:9/1/2014)... “Australia Hernia Repair Market Outlook to 2020? provides ... The report provides value, in millions of US dollars, ... within market segments –,     Synthetic Meshes ...     Composite Meshes and Biological Meshes. , Hernia ... of a hernia (a bulging of internal organs or ...
(Date:9/1/2014)... may be bad for your waistline. TV viewers ate ... excerpt from a Hollywood action film than those watching ... for helping Americans to gain weight because it encourages ... been on the medium and not the message. TV ... to eat more, including reading, listening to the radio ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Laura Brinkley, Manager, Gibson Orthopedics Pain Treatment & Cardiology Clinic, a 2014 Professional Woman of the Year 2Health News:The key to drilling wells with staying power in the developing world 2Health News:The key to drilling wells with staying power in the developing world 3Health News:2014 Lime Green Bridesmaid Dresses Offered At UWDress.com 2Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 2Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 3Health News:Australia Hernia Repair Market (Synthetic, Composite and Biological Meshes) Outlook to 2020 Report Available at MarketOptimizer.org 4Health News:Research letter: Viewers ate more while watching Hollywood action flick on TV 2
... Percutaneous coronary intervention (PCI) may be a reasonable alternative ... left main coronary artery, according to a study that ... stents and bypass surgery were used to restore blood ... treated with stenting were more likely to need a ...
... LA JOLLA, Calif., March 31 Gamma ... disease animal model efficacy,studies, according to research ... )., Presented by Steven Wagner, Ph.D., ... Keystone Symposium on Alzheimer,s Disease, data,demonstrated that ...
... Gifts and Extra Vacation Days Motivate Employees to Run on Their ... and Put Out Their Cigarettes, College Grads Are More Likely to Enroll in ... Practices Should Be ... Covered by Insurance, NEW YORK, March 31 As wellness programs grow in,popularity, ...
... COSTA MESA, Calif., March 31 CNS ... the implementation of its,agreement to roll out ... behavioral health organization (MBHO). This,agreement enables psychiatrists ... utilize,CNS Response,s rEEG medication guidance to treat ...
... 31 Cardiac Science,Corporation (Nasdaq: CSCX ... diagnosis,resuscitation, rehabilitation, and informatics products, announced today ... that it completed,certification for its HeartCentrix(R) ECG ... is a leading developer and provider,of computer-based ...
... Increased 89.39% to $15.91 million. ... $6.08 million., - FY 2007 Net Income was $6.12 million ... - Teleconference to Be Held at 9:00 ... China Yingxia,International, Inc. (OTC Bulletin Board: CYXI - News), (the "Company") ...
Cached Medicine News:Health News:Study finds support for PCI in unprotected left main disease 2Health News:Study finds support for PCI in unprotected left main disease 3Health News:Gamma Secretase Modulators Show Promise in Alzheimer's Disease Animal Model Efficacy Studies, According to Research Conducted by TorreyPines Therapeutics 2Health News:Gamma Secretase Modulators Show Promise in Alzheimer's Disease Animal Model Efficacy Studies, According to Research Conducted by TorreyPines Therapeutics 3Health News:Guardian Survey: Despite Perceived Effectiveness, Most Employees Who Participate in Wellness Programs Do Not Stay Committed 2Health News:Guardian Survey: Despite Perceived Effectiveness, Most Employees Who Participate in Wellness Programs Do Not Stay Committed 3Health News:Guardian Survey: Despite Perceived Effectiveness, Most Employees Who Participate in Wellness Programs Do Not Stay Committed 4Health News:CNS Response, Inc. Enters Agreement to Introduce rEEG(R) Platform to Managed Behavioral Health Organization 2Health News:CNS Response, Inc. Enters Agreement to Introduce rEEG(R) Platform to Managed Behavioral Health Organization 3Health News:CNS Response, Inc. Enters Agreement to Introduce rEEG(R) Platform to Managed Behavioral Health Organization 4Health News:Cardiac Science Adds NextGen to Its Roster of Certified EMR System Partners 2Health News:Cardiac Science Adds NextGen to Its Roster of Certified EMR System Partners 3Health News:Cardiac Science Adds NextGen to Its Roster of Certified EMR System Partners 4Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 2Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 3Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 4Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 5Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 6Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 7Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 8Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 9Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 10Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 11Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 12Health News:China Yingxia International, Inc. Announces Record Fourth Quarter and Year 2007 Results 13
Semmes Spinal Fusion Curettes, length 9" (229 mm), ring size 4 x 7 mm....
PG Magnum Ring Curettes, total length 12.6" (32 cm), handle length 7.8" (20 cm), handle diameter 1.12" (3 cm), working distance 4.7" (12 cm), dual-coned, precision sharpened rings....
Microsect Curette with increased cutting edge and modified shaft, 10"....
Bone Curette, 145 mm...
Medicine Products: